Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 20, 2026
Harnessing the power of microbiome, nanotechnology, and immunity against cancerJéssica Cordeiro, Carolina Macela, Ron Kleiner, et al.
Nature Nanotechnology|July 15, 2020
Immune-mediated approaches against COVID-19Helena F Florindo, Ron Kleiner, Daniella Vaskovich-Koubi, et al.
Advanced Drug Delivery Reviews|August 9, 2025
Patient-Derived 3D-Bioprinted Models of Pancreatic Cancer: Toward Personalized Therapy and Overcoming Tumor Microenvironment ChallengesDaniella Vaskovich-Koubi, Marina Green Buzhor, Anne Krinsky, et al.
Advanced Drug Delivery Reviews|March 12, 2021
Preclinical models and technologies to advance nanovaccine developmentCarina Peres, Ana I Matos, Liane I F Moura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 26, 2019
Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cellsHanan Abumanhal-Masarweh, Dana da Silva, Maria Poley, et al.
Advanced Drug Delivery Reviews|April 10, 2021
Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?Sabina Pozzi, Anna Scomparin, Sahar Israeli Dangoor, et al.
Nature Nanotechnology|August 7, 2019
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulatorsJoão Conniot, Anna Scomparin, Carina Peres, et al.
Nature Communications|March 27, 2021
P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progressionEilam Yeini, Paula Ofek, Sabina Pozzi, et al.
Science Advances|December 13, 2024
Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancersShani Koshrovski-Michael, Daniel Rodriguez Ajamil, Pradip Dey, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 8, 2024
Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 ImmunotherapyRita C Acúrcio, Ron Kleiner, Daniella Vaskovich-Koubi, et al.
Pageof 2